Interleukin-22 receptor is overexpressed in nonsmall cell lung cancer and portends a poor prognosis

The recent decade has witnessed a change of view about cancer mechanisms. Considerable evidence now suggests that the tumour microenvironment status is well correlated with disease outcome. The presence of particular immune cell types or molecules determines whether a pro- or antitumour immune response predominates within the microenvironment [1]. Accordingly, improved understanding of the factors that modulate the tumour microenvironment will be critical for the development of effective future strategies for cancer management.High expression of IL-22R1 in nonsmall cell lung cancer is an independent indicator of poor overall survival